Results 141 to 150 of about 642,672 (160)
Some of the next articles are maybe not open access.
Individual patient risk assessment and cost–benefit analysis of patiromer in AMBER – Authors' reply
Lancet, The, 2020Rajiv Agarwal, William B White
exaly
Approvals in 2016: cost–benefit challenges of new anticancer agents
Nature Reviews Clinical Oncology, 2017Philip Savage
exaly
SLNB in melanoma—DFS a true and cost-effective benefit?
Nature Reviews Clinical Oncology, 2014Alexander C J Van Akkooi
exaly
A novel insight into the cost–benefit model for the evolution of botanical carnivory
Annals of Botany, 2015Andrej Pavlovic
exaly
Barriers to promoting prefabricated construction in China: A cost–benefit analysis
Journal of Cleaner Production, 2018Geoffrey Qiping Shen
exaly

